Inhibitors of serine/threonine kinases
Current Opinion in Biotechnology
|December 1, 1995
Summary
Highly selective serine/threonine kinase inhibitors are emerging as valuable biochemical probes. These new kinase inhibitors, including those for CSBP and MAP kinase kinase-1, may drive drug development for various diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Serine/threonine kinases play crucial roles in cellular signaling pathways.
- Developing selective kinase inhibitors is essential for both biochemical research and therapeutic applications.
- Recent advancements have focused on identifying potent inhibitors for specific kinases.
Purpose of the Study:
- To highlight the significance of newly developed selective kinase inhibitors.
- To emphasize their utility as biochemical probes for studying kinase functions.
- To discuss the potential of these inhibitors in disease treatment drug development.
Main Methods:
- Review of recent literature on serine/threonine kinase inhibitors.
- Focus on inhibitors with high selectivity and potency.
- Identification of specific inhibitors for CSBP and MAP kinase kinase-1.
Main Results:
- Several highly selective serine/threonine kinase inhibitors have been recently described.
- Specific and potent inhibitors for CSBP and MAP kinase kinase-1 have been reported.
- These inhibitors are valuable tools for biochemical research.
Conclusions:
- Selective kinase inhibitors serve as important biochemical probes.
- These novel inhibitors may accelerate the development of drugs targeting diseases.
- The identification of CSBP and MAP kinase kinase-1 inhibitors marks significant progress.
Related Concept Videos
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...